Toronto Drug Strategy
Protecting your privacy is top priority for the City of Toronto. You are seeing this alert because your web browser needs to be updated to access content on toronto.ca. You will need to download and install a more recent version of your web browser to use our website.
The Toronto Drug Strategy (TDS) is a comprehensive drug strategy for the City of Toronto based on four integrated parts – prevention, harm reduction, treatment and enforcement. All four parts are needed to effectively reduce the harms of alcohol and other drug use.
The current focus of the Toronto Drug Strategy is the implementation of the Toronto Overdose Action Plan, which provides a comprehensive set of actions to prevent and respond to overdoses. The Plan combines the knowledge and expertise of people who use drugs, their family and friends, and people working in the field with best practices.
Toronto Public Health will be conducting community dialogue sessions to explore how we can change our approach to drugs and what a public health approach to drugs could look like for Canada.
The Toronto Drug Strategy Status Report 2016 documents actions taken and milestones achieved by the Toronto Drug Strategy since 2014.
Toronto Public Health worked with community partners to develop the Toronto Overdose Action Plan: Prevention & Response, which was endorsed by the Board of Health on March 20, 2017. The Plan includes a comprehensive set of actions for all orders of government to prevent and respond to drug overdoses. A short summary of the Action Plan is available.
Toronto Public Health is collaborating with the Toronto Overdose Early Warning & Alert Partnership to provide timely information about overdoses, with a current focus on opioids. Additional data and indicators may be added to the Toronto Overdose Information System as they become available.